Wed, Apr 23, 2025
Volume 13, Issue 1 (1-2025)
J. Pediatr. Rev 2025, 13(1): 57-64 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Rajasegaran V P, Tamilarasan P, Thirunavukkarasu B K. Cord Blood Alkaline Phosphatase Level as a Predictor for Neonatal Jaundice in Healthy Term Newborns. J. Pediatr. Rev 2025; 13 (1) :57-64
URL: http://jpr.mazums.ac.ir/article-1-563-en.html
URL: http://jpr.mazums.ac.ir/article-1-563-en.html
1- Department of Pediatrics, Sri Manakula Vinayagar Medical College and Hospital, Puducherry, India.
2- Department of Pediatrics, Sri Manakula Vinayagar Medical College and Hospital, Puducherry, India. ,preethi.dr@gmail.com
2- Department of Pediatrics, Sri Manakula Vinayagar Medical College and Hospital, Puducherry, India. ,
Abstract: (352 Views)
Background: Neonatal hyperbilirubinemia is one of the common and benign conditions occurring in 80% of preterm and 60% of term neonates during their first week of life. Though most cases are physiological and usually resolved without treatment, it is crucial to identify at-risk neonates of developing severe hyperbilirubinemia so that therapeutic intervention can be initiated sooner to prevent long-term morbidity. As a result, an early assessment of the risk for hyperbilirubinemia is crucial, as most healthy neonates are discharged early.
Objectives: This study aimed to compare cord blood alkaline phosphatase (ALP) levels between jaundiced and non-jaundiced neonates and to correlate the cord blood ALP levels with serum bilirubin levels in newborns with neonatal jaundice.
Methods: A hospital-based prospective cohort study was conducted on 126 healthy term newborns born to mothers without risk factors. Umbilical cord blood ALP was measured in all neonates. Then, the neonates were followed up daily for clinical jaundice for up to 3 days of life. They were subjected to further blood investigations if found icteric.
Results: This study showed a statistically significant correlation between the cord blood ALP level and the development of clinical jaundice. The median ALP level was also high in neonates who had clinical jaundice requiring phototherapy. According to the receiver operating curve (ROC), the most suitable cut-off value for cord blood ALP level for predicting neonatal jaundice with a sensitivity of 52%, specificity of 66%, positive predictive value of 60.47%, negative predictive value of 57.89%, and diagnostic accuracy of 59% was found to be more than 147 IU/L. The area under curve value for cord blood ALP was 0.665, which was satisfactory.
Conclusions: Cord blood ALP can be taken as a reliable marker in healthy term neonates to predict the risk of significant hyperbilirubinemia and the need for phototherapy despite having low sensitivity and specificity in this study.
Objectives: This study aimed to compare cord blood alkaline phosphatase (ALP) levels between jaundiced and non-jaundiced neonates and to correlate the cord blood ALP levels with serum bilirubin levels in newborns with neonatal jaundice.
Methods: A hospital-based prospective cohort study was conducted on 126 healthy term newborns born to mothers without risk factors. Umbilical cord blood ALP was measured in all neonates. Then, the neonates were followed up daily for clinical jaundice for up to 3 days of life. They were subjected to further blood investigations if found icteric.
Results: This study showed a statistically significant correlation between the cord blood ALP level and the development of clinical jaundice. The median ALP level was also high in neonates who had clinical jaundice requiring phototherapy. According to the receiver operating curve (ROC), the most suitable cut-off value for cord blood ALP level for predicting neonatal jaundice with a sensitivity of 52%, specificity of 66%, positive predictive value of 60.47%, negative predictive value of 57.89%, and diagnostic accuracy of 59% was found to be more than 147 IU/L. The area under curve value for cord blood ALP was 0.665, which was satisfactory.
Conclusions: Cord blood ALP can be taken as a reliable marker in healthy term neonates to predict the risk of significant hyperbilirubinemia and the need for phototherapy despite having low sensitivity and specificity in this study.
Type of Study: Original Article |
Subject:
Neonatology
Received: 2023/09/4 | Accepted: 2024/11/17 | Published: 2025/01/21
Received: 2023/09/4 | Accepted: 2024/11/17 | Published: 2025/01/21
Send email to the article author
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
Copyright © The Author(s);
This is an open access article distributed under the terms of the Creative Commons Attribution License (CC-By-NC),
which permits use, distribution, and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
Contact Information
